IL6 and depressive symptom measurement: Work on the Whitehall II cohort shows that individuals with increased IL-6 levels over a prolonged period of time (one, two, or three measurements over a 5-year period) have an elevated subsequent 10-year risk for development of cognitive symptoms of depression [22].